The Salk family from left: Jonas, Dora, Lee, Daniel and Herman.
Gallery of Jonas Salk
1930
New York City, New York, United States
Jonas Salk as a high school graduate.
Gallery of Jonas Salk
1930
New York City, New York, United States
Dora Press Salk and Daniel Salk with sons Herman, Jonas, and Lee.
College/University
Career
Gallery of Jonas Salk
1953
Pittsburgh, Pennsylvania, United States
Jonas Salk vaccinates a young girl for polio with the help of a nurse.
Gallery of Jonas Salk
1954
3550 Terrace St, Pittsburgh, PA 15213, United States
American virologist and medical researcher Jonas Salk, pictured at the University of Pittsburgh School of Medicine in the United States in 1954.
Gallery of Jonas Salk
1954
51 W 52nd St New York, NY 10019, USA
From left: Dr. Jonas Salk, medical researcher and developer of the polio vaccine and Basil OConnor, executive volunteer. Image dated April 26, 1954.
Gallery of Jonas Salk
1954
New Orleans, Louisiana, United States
Jonas Salk on 3.11.1954 in New Orleans.
Gallery of Jonas Salk
1954
3550 Terrace St, Pittsburgh, PA 15213, United States
Jonas Salk, inventor of the new polio vaccine, in serious portrait. Photo by Alfred Eisenstaedt.
Gallery of Jonas Salk
1955
Pittsburgh, Pennsylvania, United States
American physician Jonas Salk, developer of the polio vaccine, inoculating the vaccine to a girl.
Gallery of Jonas Salk
1955
4801 Stanton Ave, Pittsburgh, PA 15201, United States
Dr. Jonas E. Salk and a nurse administer a polio vaccine to Pauline Antloger at Sunnyside school in Pittsburgh, Pennsylvania.
Gallery of Jonas Salk
1955
United States
The inventor of the polio vaccine Jonas Salk standing with Thomas Francis during a press conference. Photo by Al Fenn.
Gallery of Jonas Salk
1955
3550 Terrace St, Pittsburgh, PA 15213, United States
Dr. Jonas E. Salk checks samples of virus-laden fluid used in the production of his vaccine, as he returns to his University of Pittsburgh laboratory, determined to make the vaccine even more effective.
Gallery of Jonas Salk
1955
3550 Terrace St, Pittsburgh, PA 15213, United States
Dr. Jonas Salk displays his polio vaccine which he developed in a University of Pittsburgh laboratory.
Gallery of Jonas Salk
1955
3550 Terrace St, Pittsburgh, PA 15213, United States
View of American scientist and physician Jonas Salk, developer of the polio vaccine, wearing a white lab coat, and smiling while holding up a bottle in the laboratory.
Gallery of Jonas Salk
1956
Pittsburgh, Pennsylvania, United States
Russian scientists visiting the United States are shown as they watched Dr. Jonas Salk administer a shot of his anti-polio vaccine to Paul Anolik, 9, in Pittsburgh. The Russians are (from left): Dr. Anatol Smordintsey; Dr. Marina Voroshilova; Dr. Mikhail Chumakov and Dr. Lev I. Lukin. At far right is Dr. Alex E. Shelkov, American escort of the Russian delegation.
Gallery of Jonas Salk
1957
New York City, New York, United States
Jonas Salk (center), developer of the polio vaccine, poses on deck of the steamship United States with his family (left to right): wife, Donna; Jonathan, 7; Darrel, 10; and Peter, 13.
Gallery of Jonas Salk
1968
United Kingdom
French painter, critic, and bestselling author Françoise Gilot and her husband, American medical researcher, and virologist Jonas Salk in the United Kingdom, 27th November 1968.
Gallery of Jonas Salk
1970
New York City, New York, United States
Dr. Jonas E. Salk, developer of the polio vaccine, and his prospective bride, French artist Francoise Gilot, are shown together in this photo released by the Salk Institute June 18. Earlier in Paris June 18, Miss Gilot's 22-year-old son, Claude, announced that the couple will be married in Paris July 9.
Gallery of Jonas Salk
1975
United States
Jonas Salk in 1975.
Gallery of Jonas Salk
1976
United States
Jonas Salk in 1976.
Gallery of Jonas Salk
1982
La Jolla, California, United States
Francoise Gilot and Jonas Salk at home circa 1982 in La Jolla, California.
Gallery of Jonas Salk
1982
La Jolla, California, United States
Francoise Gilot and Jonas Salk at home circa 1982 in La Jolla, California.
Gallery of Jonas Salk
1993
Paris, France
Francoise Gilot and Jonas Salk in Paris, France in 1993.
Achievements
Membership
Phi Beta Kappa Society
Jonas Salk was a member of the Phi Beta Kappa Society.
American Academy of Arts and Sciences
Jonas Salk was a member of the American Academy of Arts and Sciences.
American Association for the Advancement of Science
Jonas Salk was a member of the American Association for the Advancement of Science.
Awards
Meritorious Civilian Service Award
1955
Oakland, Pittsburgh, Pennsylvania, United States
Dr. Jonas Salk receives an award and a check for his research on the polio vaccine.
Polio Hall of Fame Induction
1958
5995 Spring St Building 2, Warm Springs, GA 31830, United States
Leaders in the effort against polio were honored at the opening of the Polio Hall of Fame on January 2, 1958. From left: Thomas M. Rivers, Charles Armstrong, John R. Paul, Thomas Francis Jr., Albert Sabin, Joseph L. Melnick, Isabel Morgan, Howard A. Howe, David Bodian, Jonas Salk, Eleanor Roosevelt, and Basil O'Connor. John F. Enders was ill and not able to attend.
Golden Plate Award
1976
San Diego, California, United States
Awards Council Co-Chairman and television and radio broadcaster, Lowell Thomas, presents the Golden Plate Award to Jonas Salk, developer of the first safe and effective polio vaccine, at the American Academy of Achievement’s 1976 banquet ceremonies in San Diego.
Presidential Medal of Freedom
1976
1600 Pennsylvania Ave NW, Washington, DC 20500, United States
Dr. Jonas Salk receives the Medal of Freedom from President Carter and Vice President Mondale.
California Hall of Fame Induction
2007
1020 O St, Sacramento, CA 95814, United States
Dr. Peter Salk, son of the late Dr. Jonas Salk, accepts an award on his late father's behalf by California governor Arnold Schwarzenegger during the 2007 California Hall of Fame induction ceremony at the California Museum on December 5, 2007, in Sacramento, California. Photo by John Medina.
3550 Terrace St, Pittsburgh, PA 15213, United States
Dr. Jonas E. Salk checks samples of virus-laden fluid used in the production of his vaccine, as he returns to his University of Pittsburgh laboratory, determined to make the vaccine even more effective.
3550 Terrace St, Pittsburgh, PA 15213, United States
View of American scientist and physician Jonas Salk, developer of the polio vaccine, wearing a white lab coat, and smiling while holding up a bottle in the laboratory.
Russian scientists visiting the United States are shown as they watched Dr. Jonas Salk administer a shot of his anti-polio vaccine to Paul Anolik, 9, in Pittsburgh. The Russians are (from left): Dr. Anatol Smordintsey; Dr. Marina Voroshilova; Dr. Mikhail Chumakov and Dr. Lev I. Lukin. At far right is Dr. Alex E. Shelkov, American escort of the Russian delegation.
Jonas Salk (center), developer of the polio vaccine, poses on deck of the steamship United States with his family (left to right): wife, Donna; Jonathan, 7; Darrel, 10; and Peter, 13.
5995 Spring St Building 2, Warm Springs, GA 31830, United States
Leaders in the effort against polio were honored at the opening of the Polio Hall of Fame on January 2, 1958. From left: Thomas M. Rivers, Charles Armstrong, John R. Paul, Thomas Francis Jr., Albert Sabin, Joseph L. Melnick, Isabel Morgan, Howard A. Howe, David Bodian, Jonas Salk, Eleanor Roosevelt, and Basil O'Connor. John F. Enders was ill and not able to attend.
French painter, critic, and bestselling author Françoise Gilot and her husband, American medical researcher, and virologist Jonas Salk in the United Kingdom, 27th November 1968.
Dr. Jonas E. Salk, developer of the polio vaccine, and his prospective bride, French artist Francoise Gilot, are shown together in this photo released by the Salk Institute June 18. Earlier in Paris June 18, Miss Gilot's 22-year-old son, Claude, announced that the couple will be married in Paris July 9.
Awards Council Co-Chairman and television and radio broadcaster, Lowell Thomas, presents the Golden Plate Award to Jonas Salk, developer of the first safe and effective polio vaccine, at the American Academy of Achievement’s 1976 banquet ceremonies in San Diego.
Dr. Peter Salk, son of the late Dr. Jonas Salk, accepts an award on his late father's behalf by California governor Arnold Schwarzenegger during the 2007 California Hall of Fame induction ceremony at the California Museum on December 5, 2007, in Sacramento, California. Photo by John Medina.
A New Reality: Human Evolution for a Sustainable Future
(Written by a world-famous doctor and folk hero, based on ...)
Written by a world-famous doctor and folk hero, based on population data, rich in visual imagery, elegantly designed, and clearly written, A New Reality is unique in the marketplace. Readable in one or two sittings, it is accessible to the general reader while at the same time being of essential value to policymakers and academics. Its brevity and simplicity of design belie the importance and sophistication of its message.
Jonas Edward Salk was an American physician and medical researcher. He developed the first safe and effective vaccine for polio.
Background
Jonas Edward Salk was born on October 28, 1914, in New York City, New York, United States to the family of Orthodox Jewish-Polish immigrants from the Russian Empire as the eldest of three sons. His father, Daniel B. Salk, born in Vilkmergė, Lithuania, was a garment worker, who designed lace collars and cuffs and enjoyed sketching in his spare time. He and his wife, Dora Press, born in Minsk, Belarus, encouraged their son's academic talents. Salk had two brothers, Herman and Lee.
Education
Jonas Salk attended Townsend Harris High School for the gifted. There, young Salk was both highly motivated and high achieving, graduating at the age of fifteen and enrolling in the legal faculty of the City College of New York. Ever curious, he attended some science courses and quickly decided to switch fields. Salk graduated with a bachelor's degree in science in chemistry in 1933, at the age of nineteen, and went on to New York University's School of Medicine. Initially, he scraped by on money his parents had borrowed for him; after the first year, however, scholarships and fellowships paid his way. In his senior year, Salk met the man with whom he would collaborate on some of the most important work of his career, Dr. Thomas Francis, Jr. On June 7, 1939, Salk was awarded his Doctor of Medicine. He did his postgraduate work at the University of Michigan in the laboratory of Thomas Francis.
After graduation, Salk continued working with Francis, and concurrently began a two-year internship at Mount Sinai Hospital in New York. Upon completing his internship, Salk accepted a National Research Council fellowship and moved to the University of Michigan to join Doctor Francis, who had been heading up Michigan's department of epidemiology since the previous year. Working on behalf of the United States Army, the team strove to develop a flu vaccine. Their goal was a "killed-virus" vaccine - able to kill the live flu viruses in the body, while simultaneously producing antibodies that could fight off future invaders of the same type, thus producing immunity. By 1943, Salk and Francis had developed a formalin-killed-virus vaccine, effective against both type A and B influenza viruses, and were in a position to begin clinical trials.
In 1946, Salk was appointed assistant professor of epidemiology at Michigan. Around this time he extended his research to cover not only viruses and the body's reaction to them but also their epidemic effects in populations. Salk then became Associate Research Professor of Bacteriology at the University of Pittsburgh's School of Medicine in 1947.
Salk's early work at Pittsburgh was a continuation of his Michigan influenza vaccine research. Next, he focused on carrying out part of the systematic classification of the various strains of poliovirus. As that program neared completion, he began research on a vaccine for the prevention of polio. The central element in Salk's efforts was the development of a non-infectious, or "killed virus," vaccine. He used tissue-culture methods to produce the poliovirus and employed a formaldehyde solution to inactivate it.
By June 1952, Salk and his team had developed what they considered to be a promising experimental polio vaccine, and began testing the vaccine in local children. A massive, nationwide field trial of the vaccine, involving a total of 1,831,702 children in grades one through three, began on April 26, 1954. 441,131 children received the Salk vaccine, 201,229 were injected with a placebo, and the remainder served as uninjected controls. The field trial was coordinated by Thomas Francis at the University of Michigan, who reached the conclusion that the vaccine was "safe, effective, and potent." Francis presented his report in Ann Arbor on April 12, 1955, coincidentally the tenth anniversary of the death of President Franklin D. Roosevelt, who himself had been a victim of polio. Salk's work was funded by the National Foundation for Infantile Paralysis, which raised money from the public through its "March of Dimes" campaign.
By the end of April 1955, around 5 million children had been inoculated with commercially produced Salk vaccine. Unfortunately, a large batch of vaccine manufactured by Cutter Laboratories (Berkeley, California) actually caused polio in 250 cases. The Cutter vaccine was taken off the market and more stringent specifications for the manufacture of the vaccine were put in place. On May 27, 1955, the Surgeon-General announced that the vaccination program could be resumed.
By 1960 Salk had chosen San Diego as the site for what would become the Salk Institute for Biological Studies. A substantial amount of start-up funds came from the National Foundation-March of Dimes. He served as Director of the Salk Institute from 1963-1975.
Salk also conducted important research on the prevention and treatment of influenza, multiple sclerosis, cancer, and acquired immune deficiency syndrome. In his later years, he wrote and lectured extensively on an evolutionary perspective to provide insight on ways to improve the human condition.
Throughout the 1970s and '80s, Salk wrote books about science, philosophy, and mankind. In The Survival of the Wisest, Salk applied Charles Darwin’s ideas on survival of the fittest to the need for humankind to be educated and have knowledge. And in World Population and Human Values: A New Reality, he and his psychiatrist son, Doctor Jonathan Salk, discussed the interplay between world population growth and human values.
Salk’s groundbreaking vaccine led to a dramatic decrease in polio cases in the United States; in the four years before the vaccine became available, an average of 40,000 polio cases per year were reported in the United States. By 1961 the number of reported cases had dropped by 97 percent. Founding the Salk Institute for Biological Studies in La Jolla in 1963 was Salk’s second triumph. He was aided with a $20 million grant from the National Science Foundation and support from the March of Dimes.
Among his many honors was the Presidential Medal of Freedom, awarded in 1977. He also received Lasker Award for clinical medical research in 1956, the United States Order of Merit, and a Congressional Gold Medal.
Born and raised in Orthodox Jewish family, Jonas Salk was an atheist.
Politics
J. Edgar Hoover, director of the Federal Bureau of Investigation, wrote that the FBI was told Salk's political leanings were leftist, but ultimately the government concluded in 1952 that Salk was loyal to his country.
Views
Contrary to the era’s prevailing scientific opinion, Salk believed his vaccine, composed of “killed” poliovirus, could immunize without risk of infecting the patient.
Despite Salk's confidence, many of his colleagues were skeptical, believing that a killed-virus vaccine could not possibly be effective. His dubious standing was further compounded by the fact that he was relatively new to polio vaccine research; some of his chief competitors in the race to develop the vaccine - most notably Albert Sabin, the chief proponent for a live-virus vaccine - had been at it for years.
As the field narrowed, the division between the killed-virus and the live-virus camps widened, and what had once been a polite difference of opinion became a serious ideological conflict. Salk and his chief backer, the National Foundation for Infantile Paralysis, were lonely in their corner. Salk failed to let his position in the scientific wilderness dissuade him, and he continued, undeterred, with his research. To test his vaccine's strength, in early 1952, Salk administered a type I vaccine to children who had already been infected with the poliovirus. Afterward, he measured their antibody levels. His results clearly indicated that the vaccine produced large amounts of antibodies. Buoyed by this success, Salk administered the vaccine to volunteers who had not had polio, including himself, his lab scientist, his wife, and their children. All developed anti-polio antibodies and experienced no negative reactions to the vaccine.
Membership
Jonas Salk was a member of the Phi Beta Kappa Society, American Academy of Arts and Sciences, and American Association for the Advancement of Science.
Phi Beta Kappa Society
,
United States
American Academy of Arts and Sciences
,
United States
American Association for the Advancement of Science
,
United States
Personality
Jonas Salk was a controversial person. He defied conventional thinking about the design of vaccines, but refused to defend himself publicly when criticized by fellow scientists about his approach. He was usually cautious and pragmatic but began constructing the institute without enough money to finish it. Salk was passionate about ideas, yet spoke in a dull monotone. He was a freethinker who lived a scripted life.
Although Salk quickly became a world hero, he didn’t enjoy losing his anonymity and gaining the responsibilities that came with being a public figure. Salk exercised and practiced yoga.
Quotes from others about the person
"My father would insist on also making COVID-19 screening, treatment and vaccination available to all of us, regardless of where we live or our social or economic standing. He would argue that doing so is not only morally right, but profoundly in our national and global interest. When it comes to infectious disease, health - unlike wealth - can’t be hoarded by the few. As long as a virus is circulating in an unimmunized population, it’s a threat to all, and it’s in all our interests to contain, prevent and eradicate it." - Doctor Jonathan Salk, psychiatrist, son of Jonas Salk
"My father was a scientist and an evidence-based thinker. Based on what he knew of evolution, he believed evolutionary pressures would nudge us in the right direction. He would have seen the pandemic as just such a nudge and would have appreciated the irony that a deadly virus, the same thing that prompted the advancement of medical science 65 years ago, might lead us now to advance social evolution toward a healthier, more cooperative, interdependent world where we can not only survive but thrive - if we only listen." - Doctor Jonathan Salk, psychiatrist, son of Jonas Salk
Interests
yoga
Philosophers & Thinkers
Buckminster Fuller, Leo Szilard
Politicians
Franklin Delano Roosevelt
Writers
Norman Cousins
Sport & Clubs
horse racing
Connections
On June 8, 1939, Jonas Salk married Donna Lindsay, a psychology major who was employed as a social worker. The couple eventually had three sons: Darrell, Jonathan, and Peter. In 1968, they divorced, and in 1970, Salk married French painter Françoise Gilot, the former mistress of artist Pablo Piccaso.
Jonas Salk was engaged in a four decade long rivalry with Doctor Albert Sabin. Sabin's live oral polio vaccine was developed at about the same time as Salk's injected killed virus vaccine, and the debate rages on over which vaccine has been more effective in combating polio in the long run.